Építés alatt – nem éles oldal
Belépés
Not yet taking people in Szlovénia1/2. fázis

CELL-BASED IMMUNOTHERAPY FOR TREATMENT OF TRIPLE NEGATIVE BREAST CANCER STAGES II AND III

Key facts

Where
Ljubljana, SzlovéniaSee the site
Phase
1/2. fázis

Where in Szlovénia

  • Institute of Oncology LjubljanaLjubljana, SzlovéniaToborzás még nem indult

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Celica d.o.o.
Trial code
EU 2023-506019-16-03
Record updated
2026. március 31.